eMedEd, with eMedEvents as the marketing partner, and in collaboration with AAPI and FAPI, presents the HerHealth Oncology Congress 2025, a hybrid event on March 1-2, 2025, at the Renaissance Orlando Resort & Spa, Florida. This event brings together oncologists, nurses, and healthcare professionals to explore advancements in Breast Cancer, Ovarian Cancer, Urothelial Cancer, Gastric Cancer, HPV and cancers, AI in oncology, and more. As the name suggests, "HerHealth Oncology Congress 2025" underscores our commitment to focus on cutting-edge research, innovative treatments, and multidisciplinary approaches to enhance practicing women-oncological health care.
SOMERVILLE, N.J., Jan. 29, 2025 /PRNewswire-PRWeb/ -- HerHealth Oncology Congress 2025, the leading conference for women's oncology, will take place on March 1-2, 2025, at the Renaissance Orlando Resort & Spa in Lake Buena Vista, Florida, USA. Organized by eMedEd with eMedEvents as its marketing partner, in collaboration with the American Association of Physicians of Indian Origin (AAPI) and the Florida Association of Physicians of Indian Origin (FAPI), it aims to bring together healthcare professionals to explore advancements in women's oncology.
The HerHealth Oncology Congress 2025, a hybrid in-person and virtual event, addresses the challenges and opportunities faced by oncologists, gynecological oncologists, primary care providers, and other healthcare professionals in the evolving landscape of oncology care, advancements in treatment, and women's cancer research. Attendees can engage with leading oncology experts, network with influential stakeholders in women's health, and gain insights into cutting-edge innovations shaping the future of oncological care.
Why is HerHealth Oncology Congress 2025 Different?
While there are numerous oncology conferences that are very broadly focused on cancer research and treatment, HerHealth Oncology Congress 2025 distinguishes itself by focusing specifically on women's oncology. This targeted approach allows in-depth discussions on cancers predominantly affecting women, fostering a more specialized and relevant learning experience for attendees.
Key Highlights of the Oncology Conference 2025
- Comprehensive Agenda: The conference will cover a wide range of topics, including breast cancer, ovarian cancer, uterine cancer, colorectal cancer, lung cancer, skin cancer, and the application of artificial intelligence in oncology. These sessions aim to provide attendees with the latest insights and advancements in women's oncology.
- Accreditation: Participants will have the opportunity to earn 10 AMA PRA Category 1 Credits™ for physicians and 10 contact hours for nurses upon full participation. eMedEd is accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the California Board of Registered Nursing (CBRN), ensuring the highest standards of continuing medical education.
- Networking Opportunities: Attendees will have the chance to connect with a diverse group of healthcare professionals, researchers, and industry experts in the field of oncology, facilitating valuable collaborations and knowledge exchange.
The HerHealth Oncology Congress 2025 will feature thirteen esteemed faculty, sharing insights during a series of engaging, interactive sessions over the two-day event. Panel sessions at the summit will feature leading experts in oncology, including:
- Barbara McAneny, MD - Former President, American Medical Association (AMA)
- Satheesh K. Kathula, MD, FACP, DipABLM - President, American Association of Physicians from Indian Origin (AAPI)
- Tarun Wasil, MD - Hematologist-Oncologist, St. Francis Hospital & Heart Center
- Brian Slomovitz, MD, MS - Director, Gynecologic Oncology, Mount Sinai Medical Center, Miami Beach, Florida
- Dr. Libia F. Scheller, PhD, MBA - Global Head of Oncology Cooperative Groups & Strategic Alliances, Bayer Health Care Pharmaceuticals
- John P. Diaz, MD - Chief of Gynecologic Oncology, Director of Robotic Surgery, Baptist Health South Florida
- Diwakar Davar, MD - Clinical Director, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Center
- Marie Catherine Lee, MD, FACS - Associate Professor, Moffitt Cancer Center's Comprehensive Breast Program
- Tracey O'Connor, MD—Associate Member, Department of Breast Oncology at Moffitt Cancer Center; Associate Professor of Oncology, Roswell Park Comprehensive Cancer Center; Clinical Associate Professor, The State University of New York, Buffalo
- Matthew Mills, MD - Assistant Member, Department of Radiation Oncology, Moffitt Cancer Center
- Alka Arora, MD - Medical oncologist and hematologist, Orlando Health Cancer Institute
- Praveen Ranganath, MD—Medical oncologist, Orlando Health Cancer Institute; Member of Orlando Health Medical Group
- Akash Parvatikar, PhD (Computational Biology) - HistoWiz AI Scientist, Carnegie Mellon University
Dr. Priya Korrapati, President and CEO of eMedEd, Inc., emphasizes the significance of the HerHealth Oncology Congress 2025 as a pivotal event dedicated to advancing women's oncology. "eMedEd, in collaboration with eMedEvents and AAPI, presents the HerHealth Oncology Congress 2025, a hybrid event on March 1-2, 2025, at the Renaissance Orlando Resort & Spa, Florida. This event brings together oncologists, nurses, and healthcare professionals to explore advancements in breast cancer, ovarian cancer, uterine cancer, colorectal cancer, lung cancer, skin cancer, and the application of artificial intelligence in oncology. True to its name, the HerHealth Oncology Congress 2025 is committed to fostering cutting-edge research, innovative treatments, and multidisciplinary approaches to enhance women's oncological healthcare."
"What sets HerHealth Oncology Congress 2025 apart is its exclusive focus on advancing women's oncological healthcare through a multidisciplinary lens," Dr. Korrapati adds. "Unlike broader oncology conferences, we prioritize the latest research and treatment innovations specifically in cancers that predominantly affect women, ensuring that attendees gain targeted insights relevant to their practice. This event is designed to foster meaningful discussions, connect experts from various specialties, and provide practical, evidence-based strategies that oncologists can immediately integrate into patient care. By attending, healthcare professionals will not only expand their expertise but also become part of a movement dedicated to transforming the future of women's cancer treatment."
About the Organizers
- eMedEd: A women-owned non-profit organization dedicated to providing state-mandated Continuing Medical Education (CME) courses to healthcare professionals. Their mission is to empower HCPs with the knowledge and skills needed to deliver exceptional patient care.
- eMedEvents: A renowned CME/CE marketplace that connects healthcare professionals with cutting-edge CME/CE opportunities, facilitating access to the latest advancements in the medical field.
- AAPI: The American Association of Physicians of Indian Origin is the largest ethnic medical organization in the United States, representing over 80,000 practicing physicians and 40,000 medical students, residents, and fellows of Indian origin. AAPI focuses on advancing healthcare equity and supporting professional development.
- FAPI: The Florida Association of Physicians of Indian Origin (FAPI) is a proud collaborative partner for the HerHealth Oncology Congress 2025, bringing together its dynamic network of 700+ healthcare professionals dedicated to advancing patient care, research, and medical education. This partnership strengthens our mission to enhance oncology expertise and improve women's cancer care.
As advancements in oncology continue to redefine patient care, this event serves as a crucial platform for oncologists, primary care physicians, OB/GYNs, and healthcare professionals to stay ahead of the curve. Featuring renowned experts, groundbreaking research, and emerging technologies, the goal of the HerHealth Oncology Congress 2025 is to impart practical knowledge and new perspectives that directly impact clinical practice.
Learn more and register for the HerHealth Oncology Congress 2025
*Speakers and topics listed above are subject to change without prior notice.
Media Contact
Dr. Priya Korrapati, eMedEd. Inc., 1 +1 (303) 521-5872, [email protected], eMedEd. Inc.
SOURCE eMedEd. Inc.
![](https://rt.prnewswire.com/rt.gif?NewsItemId=UN04839&Transmission_Id=202501290905PR_NEWS_USPR_____UN04839&DateId=20250129)
Share this article